Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood–brain barrier: Protection by the antioxidant N-acetylcysteine
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Impairment in two blood-brain barrier (BBB) efflux transporters, p-glycoprotein (Pgp) and low-density lipoprotein receptor-related protein-1 (LRP-1) are thought to contribute to the progression of Alzheimer’s disease (AD) by resulting in the brain accumulation of their substrate amyloid beta peptide (Aβ). The initial cause of impaired efflux, however, is unknown. We have shown that induction of systemic inflammation by intraperitoneal administration of lipopolysaccharide impairs the efflux of Aβ from the brain, suggesting that systemic inflammation could be one such initiator. In this study, we determined whether pre-administration of the antioxidant N-aceytlcysteine (Nac) has a protective effect against LPS-induced Aβ transporter dysfunction. Our findings were that Nac protected against LPS-induced Aβ transport dysfunction at the BBB through an LRP-1-dependent and Pgp-independent mechanism. This was associated with Nac exerting antioxidant effects in the periphery but not the brain, despite an increased rate of entry of Nac into the brain following LPS. We also found that Nac pre-administration resulted in lower blood levels of the cytokines and chemokines interferon-γ, interleukin-10, CCL2, CCL4, and CL5, but only lowered CCL4 in the cerebral cortex and hippocampus. Finally, we observed that hippocampal cytokine responses to LPS were decreased compared to cortex. These findings demonstrate a novel mechanism by which antioxidants prevent Aβ accumulation in the brain caused by inflammation, and therefore protect against AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Increased oxidative stress in obesity and its impact on metabolic syndrome
Furukawa, S., Fujita, T., Shimabukuro, M., Iwaki, M., Yamada, Y., Nakajima, Y., Nakayama, O., Makishima, M., Matsuda, M., & Shimomura, I. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21625 · Cited by 5,508 · cited 2×
“, 2010), as well as metabolic syndrome (Furukawa et al., 2004; Hansel et al., 2004) which is a risk factor for AD (Alzheimer’s Association, 2012).”
Crosstalk of reactive oxygen species and NF-κB signaling
Morgan, M. J., & Liu, Z.-G. (2011) · Cell Research · doi:10.1038/cr.2010.178 · Cited by 3,505 · cited 1×
“ROS produced in response to inflammatory stimuli can exacerbate inflammation by activating a number of signaling molecules, including NFk-B, AP-1 MAPK (Hsu and Wen, 2002; Lo et al., 1996; Morgan and Liu, 2011), and promoting inflammasome activation (Martinon, 2010).”
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490 · cited 3×
“Ab plaque, however, begins to accumulate in the neocortex first, and hippocampal pathology occurs later as the disease advances (Thal et al., 2002).”
Braak, H., Alafuzoff, I., Arzberger, T., Kretzschmar, H., & Del Tredici, K. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0127-z · Cited by 3,172 · cited 2×
“Tau neurofibrillary tangles begin to accumulate in the hippocampus and surrounding areas, and extend throughout the neocortex as neuropathological severity increases (Braak et al., 2006).”
Shibata, M., Yamada, S., Kumar, S. R., Calero, M., Bading, J., Frangione, B., Holtzman, D. M., Miller, C. A., Strickland, D. K., Ghiso, J., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10498 · Cited by 1,413 · cited 4×
“Deficits in both LRP-1 and Pgp at the BBB have been proposed to cause Ab accumulation in the brain (Cirrito et al., 2005; Hartz et al., 2010; Jaeger et al., 2009a,b; Shibata et al., 2000).”
InfluentialApolipoprotein E controls cerebrovascular integrity via cyclophilin A
Bell, R. D., Winkler, E. A., Singh, I., Sagare, A. P., Deane, R., Wu, Z., Holtzman, D. M., Betsholtz, C., Armulik, A., Sallstrom, J., et al. (2012) · Nature · doi:10.1038/nature11087 · Cited by 1,293 · cited 3×
“Cyclophilin A is also upregulated by ROS, and participates in the vascular inflammatory process by activating NF-kB signaling (Bell et al., 2012; Satoh et al., 2010).”
Systemic inflammation and disease progression in Alzheimer disease
Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., & Perry, V. H. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b6bb95 · Cited by 1,139 · cited 2×
“suggesting that systemic inflammation plays a role in the onset and progression of AD (Holmes et al., 2009; Tan et al., 2007).”
The metabolic syndrome, inflammation, and risk of cognitive decline
Yaffe, K. (2004) · JAMA · doi:10.1001/jama.292.18.2237 · Cited by 1,025 · cited 1×
“The peripheral actions of Nac may therefore be important parameters to consider for individuals with risk factors for AD such as systemic inflammation and metabolic syndrome (Cunningham, 2011; Tan et al., 2007; Yaffe et al., 2004), due to the association with decreased BBB efflux of Ab.”
Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786
Lee, J. W., Lee, Y. K., Yuk, D. Y., Choi, D. Y., Ban, S. B., Oh, K. W., & Hong, J. T. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-37 · Cited by 772
Cirrito, J. R. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25247 · Cited by 660 · cited 3×
“Deficits in both LRP-1 and Pgp at the BBB have been proposed to cause Ab accumulation in the brain (Cirrito et al., 2005; Hartz et al., 2010; Jaeger et al., 2009a,b; Shibata et al., 2000).”
The blood-brain barrier and immune function and dysfunction
Banks, W. A., & Erickson, M. A. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.031 · Cited by 523 · cited 1×
“Both inflammation and oxidative stress have been shown to alter BBB function (Abbott, 2000; Banks and Erickson, 2010; Freeman and Keller, 2012; Haorah et al., 2007).”
Self-citationHsu, H.-Y., & Wen, M.-H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111883200 · Cited by 519 · cited 1×
“ROS produced in response to inflammatory stimuli can exacerbate inflammation by activating a number of signaling molecules, including NFk-B, AP-1 MAPK (Hsu and Wen, 2002; Lo et al., 1996; Morgan and Liu, 2011), and promoting inflammasome activation (Martinon, 2010).”
RAGE, LRP-1, and amyloid-beta protein in Alzheimer’s disease
Donahue, J. E., Flaherty, S. L., Johanson, C. E., Duncan, J. A., Silverberg, G. D., Miller, M. C., Tavares, R., Yang, W., Wu, Q., Sabo, E., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0115-3 · Cited by 519 · cited 3×
“Two predominant efflux transporters have been implicated in this process: low-density lipoprotein receptor-related protein-1 (LRP-1) and pglycoprotein (Pgp) (Brenn et al., 2011; Cirrito et al., 2005; Donahue et al., 2006; Hartz et al., 2010; Jaeger et al., 2009a,b; Pflanzner et al., 2011; Shibata et al., 2000; van Ass…”
Farr, S. A., Poon, H. F., Dogrukol‐Ak, D., Drake, J., Banks, W. A., Eyerman, E., Butterfield, D. A., & Morley, J. E. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01580.x · Cited by 459 · cited 6×
“More sensitive methods show, however, that Nac crosses the BBB and therefore can act locally in the CNS (Farr et al., 2003).”
InfluentialSelf-citationInflammatory markers and the risk of Alzheimer disease: The Framingham Study
Tan, Z. S., Beiser, A. S., Vasan, R. S., Roubenoff, R., Dinarello, C. A., Harris, T. B., Benjamin, E. J., Au, R., Kiel, D. P., Wolf, P. A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000263217.36439.da · Cited by 440
Inflammation and Alzheimer’s disease
Lee, Y.-J., Han, S. B., Nam, S.-Y., Oh, K.-W., & Hong, J. T. (2010) · Archives of Pharmacal Research · doi:10.1007/s12272-010-1006-7 · Cited by 396
Padurariu, M., Ciobica, A., Hritcu, L., Stoica, B., Bild, W., & Stefanescu, C. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.033 · Cited by 378 · cited 2×
“Increased serum markers of oxidative stress have been observed in individuals with AD and mild cognitive impairment (MCI) (Padurariu et al., 2010), as well as metabolic syndrome (Furukawa et al., 2004; Hansel et al., 2004) which is a risk factor for AD (Alzheimer’s Association, 2012).”
Blood–brain barrier P-glycoprotein function in Alzheimer's disease
van Assema, D. M. E., Lubberink, M., Bauer, M., van der Flier, W. M., Schuit, R. C., Windhorst, A. D., Comans, E. F. I., Hoetjes, N. J., Tolboom, N., Langer, O., et al. (2012) · Brain · doi:10.1093/brain/awr298 · Cited by 318
Jaeger, L. B., Dohgu, S., Sultana, R., Lynch, J. L., Owen, J. B., Erickson, M. A., Shah, G. N., Price, T. O., Fleegal-Demotta, M. A., Butterfiled, D. A., et al. (2009) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.01.017 · Cited by 281 · cited 6×
“Decreased efflux has also been reported for Ab during systemic inflammation (Jaeger et al., 2009a,b).”
InfluentialSelf-citationCarnevale, D., Mascio, G., D'Andrea, I., Fardella, V., Bell, R. D., Branchi, I., Pallante, F., Zlokovic, B., Yan, S. S., & Lembo, G. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.195511 · Cited by 241
Controlled trial of N-acetylcysteine for patients with probable Alzheimer’s disease
Adair, J. C., Knoefel, J. E., & Morgan, N. (2001) · Neurology · doi:10.1212/wnl.57.8.1515 · Cited by 240
Systemic inflammation and delirium: important co-factors in the progression of dementia
Cunningham, C. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390945 · Cited by 153 · cited 1×
“The peripheral actions of Nac may therefore be important parameters to consider for individuals with risk factors for AD such as systemic inflammation and metabolic syndrome (Cunningham, 2011; Tan et al., 2007; Yaffe et al., 2004), due to the association with decreased BBB efflux of Ab.”
Erickson, M. A., Hartvigson, P. E., Morofuji, Y., Owen, J. B., Butterfield, D. A., & Banks, W. A. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-150 · Cited by 145 · cited 4×
“We have recently shown that LPS does not significantly alter the expression of LRP-1 or Pgp in isolated brain microvessels (Erickson et al., 2012).”
InfluentialSelf-citationLRP1 mediates bidirectional transcytosis of amyloid-β across the blood-brain barrier
Pflanzner, T., Janko, M. C., André-Dohmen, B., Reuss, S., Weggen, S., Roebroek, A. J. M., Kuhlmann, C. R. W., & Pietrzik, C. U. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.025 · Cited by 141
Cited by
The chemistry and biological activities of N-acetylcysteine
Samuni, Y., Goldstein, S., Dean, O. M., & Berk, M. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.04.016 · Cited by 876
Banks, W. A., Gray, A. M., Erickson, M. A., Salameh, T. S., Damodarasamy, M., Sheibani, N., Meabon, J. S., Wing, E. E., Morofuji, Y., Cook, D. G., et al. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0434-1 · Cited by 636
“The antioxidant N-acetylcysteine (NAC) protects the brain endothelial cell (BEC) from oxidative stress induced by methamphetamine and antiretroviral drugs [25, 26] and reverses the decreased brain-to-blood transport of amyloid beta peptide induced by LPS [27].”
BackgroundSelf-citationZhao, Z., Ning, J., Bao, X.-Q., Shang, M., Ma, J., Li, G., & Zhang, D. (2021) · Microbiome · doi:10.1186/s40168-021-01107-9 · Cited by 616
“Based on our current results, we speculate that the intestinal inflammation induced by bacterial elements through the LPS-activated TLR4/MyD88/NF-κB signaling pathway together with the following sustained and relatively severe disruption of the intestinal barrier that can leak pro-inflammatory factors into the circula…”
BackgroundThe gut-brain axis: is intestinal inflammation a silent driver of Parkinson’s disease pathogenesis?
Houser, M. C., & Tansey, M. G. (2017) · npj Parkinson's Disease · doi:10.1038/s41531-016-0002-0 · Cited by 588
Blood–Brain Barrier Dysfunction as a Cause and Consequence of Alzheimer's Disease
Erickson, M. A., & Banks, W. A. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.135 · Cited by 572
Self-citation
Metadata
- Authors
- Erickson, M. A., Hansen, K., & Banks, W. A.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2012-10
- Volume
- 26
- Issue
- 7
- Pages
- 1085-1094
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2059341594
- Cited by
- 98
- References
- 25
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.